Not known Factual Statements About 6α-hydroxy Paclitaxel
Truqap is often a kinase inhibitor that works by blocking pathways that support the cancer cells endure and improve, so lowers cancer development. Truqap is from a category of medicines named an AKT inhibitor. Truqap obtained FDA approval on November seventeen, 2023, soon after optimistic outcomes through the CAPItello-291 Phase III demo. How effec